On this episode of Molecular Moments, Lynn Kamen, Ph.D., and Michelle Miller, Ph.D. DABT discuss their very different journeys to BioAgilytix as Scientific Officers. Despite different initial career paths, they both ended up working in bioanalysis, supporting the development of novel therapeutics. The pair discuss their favorite aspects of their day-to-day tasks at BioAgilytix, Scientific Office Hours, mentors (unofficial or otherwise), and the art of writing scientific papers. Additionally, they discuss the importance of bioanalysis, why transparency to the public is essential, and future challenges for the industry.

CEO of BioAgilytix Davide Molho, Discusses Passion, Innovation, and the Future of the CRO Industry
41:34

Drs. Shashank Gorityala, Ben Nie, and Amanda Hays talk LC/MS bioanalysis, platforms, matrices, workflows, and regulations.
46:24

Adam Stasio Talks, Large Data Sets, Breaking Down Problems, and Tech-Driven Solutions
41:00